ES373631A1 - Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. - Google Patents

Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.

Info

Publication number
ES373631A1
ES373631A1 ES373631A ES373631A ES373631A1 ES 373631 A1 ES373631 A1 ES 373631A1 ES 373631 A ES373631 A ES 373631A ES 373631 A ES373631 A ES 373631A ES 373631 A1 ES373631 A1 ES 373631A1
Authority
ES
Spain
Prior art keywords
poultry
disease virus
virus
live attenuated
virus vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES373631A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Publication of ES373631A1 publication Critical patent/ES373631A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES373631A 1968-11-18 1969-11-18 Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. Expired ES373631A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB54717/68A GB1292803A (en) 1968-11-18 1968-11-18 Improvements relating to the production of antigens

Publications (1)

Publication Number Publication Date
ES373631A1 true ES373631A1 (es) 1972-05-16

Family

ID=10471867

Family Applications (1)

Application Number Title Priority Date Filing Date
ES373631A Expired ES373631A1 (es) 1968-11-18 1969-11-18 Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.

Country Status (15)

Country Link
US (1) US3674861A (es)
JP (1) JPS4935144B1 (es)
BE (1) BE741865A (es)
BG (1) BG20617A3 (es)
BR (1) BR6914244D0 (es)
CA (1) CA966779A (es)
DE (1) DE1957747A1 (es)
DK (1) DK131609C (es)
ES (1) ES373631A1 (es)
FR (1) FR2023537B1 (es)
GB (1) GB1292803A (es)
IL (1) IL33318A (es)
IT (1) IT1056006B (es)
NL (1) NL6917014A (es)
RO (1) RO61995A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US4071618A (en) * 1974-09-03 1978-01-31 Research Foundation For Microbial Diseases Of Osaka University Process for preparing virus disease live vaccines
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
DE7833527U1 (de) * 1978-11-11 1979-02-22 Silbernagel, Hermann, 6800 Mannheim Vorrichtung zum aufstellen von schildern
US4554158A (en) * 1983-04-07 1985-11-19 Simonsen Laboratories, Inc. Modified live sendai virus vaccine for administering through an aerosol and method of producing the same
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
EP0748867A1 (en) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek's disease vaccine
US6108969A (en) * 1998-08-14 2000-08-29 Danna; Nicholas H. Tubular landscape edging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH63A (de) * 1889-01-08 Oesterr Alpine Montan Hydraulische Presse zur Herstellung von Bleiumhüllungen an Kabeln und von Bleiröhren

Also Published As

Publication number Publication date
CA966779A (en) 1975-04-29
FR2023537A1 (es) 1970-08-21
RO61995A (es) 1977-06-15
DK131609B (da) 1975-08-11
IL33318A (en) 1973-06-29
US3674861A (en) 1972-07-04
IL33318A0 (en) 1970-01-29
BE741865A (es) 1970-05-19
IT1056006B (it) 1982-01-30
FR2023537B1 (es) 1973-06-08
NL6917014A (es) 1970-05-20
BG20617A3 (bg) 1975-12-05
BR6914244D0 (pt) 1973-02-20
DE1957747A1 (de) 1970-06-11
JPS4935144B1 (es) 1974-09-20
GB1292803A (en) 1972-10-11
DK131609C (da) 1976-01-19

Similar Documents

Publication Publication Date Title
Heddleston et al. Fowl cholera: cross-immunity induced in turkeys with formalin-killed in-vivo-propagated Pasteurella multocida
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
Dorson et al. Infectious pancreatic necrosis virus of salmonids: biological and antigenic features of a pathogenic strain and of a non‐pathogenic variant selected in RTG‐2 cells
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
ES336810A1 (es) Un metodo para producir una cepa de celulas.
EP0125245B1 (en) Propagation of hemorrhagic enteritis virus in a turkey cell line
US4400472A (en) Novel rabies virus strain and a process for its preparation
GB1316168A (en) Poultry vaccine
US4980162A (en) Live vaccine for contagious diseases of chickens
Cullen et al. Diagnosis of Mycoplasma infection in poultry previously vaccinated with killed adjuvant vaccines
US3548055A (en) Infectious bursal disease vaccine
US3331736A (en) Modified laryngotracheitis vaccine
Harry et al. Laboratory and field trials on a formalin inactivated vaccine for the control of Pasteurella anatipestifer septicaemia in ducks
Sevoian et al. The effects of JM and JM-V leukosis strains on chicks vaccinated with herpes virus of turkeys (HVT)
Moscovici et al. Transformation of chick fibroblast cultures with avian myeloblastosis virus
ES2053732T3 (es) Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
Bernkopf et al. Characteristics of a fixed rabies virus cultivated on developing chick embryos
Eidson et al. Maternal transfer of resistance against development of Marek's disease tumors
Schild et al. Demonstration of a tumour and transplantation antigen in hamster tumours induced by an avian adenovirus (CELO)
US2998349A (en) Vaccine against avian respiratory infection
Karunakaran et al. Seroprevalence of infectious bursal disease (IBD) in parts of Tamil Nadu, India
GB1058340A (en) Transmissible gastroenteritis vaccines and method of producing the same
Williams et al. Pathogenicity of latent infectious laryngotracheitis virus in chickens
Wooley The preservation of lymphocytic choriomeningitis and St. Louis encephalitis viruses by freezing and drying in vacuo
Siegel In Vitro Cultivation of Mouse Ascites Tumour Cells for Virus–Host Cell Studies